ANAB
AnaptysBio Inc
51.00$
-1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 951.5% | 930.6% | 372.3% | 516.0% | 382.8% | 140.6% | 98.8% | 148.3% | 169.9% | 41.2% | -99.8% | 2.4% | -16.4% | |
| -851.5% | -830.6% | -272.3% | -416.0% | -282.8% | -40.6% | 1.2% | -48.3% | -69.9% | 58.8% | 199.8% | 97.6% | 116.4% | |
| 951.5% | 930.6% | 453.8% | 516.0% | 382.8% | 140.6% | 98.8% | 148.3% | 169.9% | 41.2% | 23.6% | 132.5% | 55.4% | |
| 308.7% | 306.6% | 114.1% | 171.9% | 84.7% | 35.2% | 23.6% | 50.9% | 47.7% | 13.4% | 14.6% | 102.5% | 27.0% | |
| 308.7% | 306.6% | 195.6% | 171.9% | 84.7% | 35.2% | 23.6% | 50.9% | 47.7% | 13.4% | 138.0% | 233.1% | 98.9% | |
| -1,160.2% | -1,137.2% | -467.9% | -587.8% | -367.5% | -75.8% | -22.4% | -99.2% | -117.5% | 45.5% | 61.8% | -135.5% | 17.6% | |
| 126.0% | 133.5% | 55.1% | 88.0% | 99.8% | 51.3% | 40.4% | 65.0% | 88.1% | 29.5% | 18.2% | 81.6% | 35.6% | |
| -1,151.6% | -1,124.4% | -468.8% | -612.0% | -425.2% | -109.4% | -50.5% | -141.5% | -173.3% | 19.8% | 45.9% | -206.8% | -11.5% | |
| 126.0% | 133.6% | 0.0% | 7.8% | 0.1% | -2.0% | 0.0% | 0.2% | 0.2% | – | 0.1% | 0.2% | – | |
| -1,151.6% | -1,124.4% | -468.8% | -612.0% | -425.3% | -109.4% | -50.5% | -141.6% | -173.5% | 19.8% | 45.8% | -206.9% | -11.5% | |
| -1,008.7% | -973.0% | -384.6% | -515.6% | -320.0% | -56.1% | -8.8% | -74.2% | -82.6% | 50.1% | 64.7% | -122.8% | 25.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.